Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy

Fig. 1

Representative immunohistochemical (IHC) and hematoxylin–eosin (H&E) staining. a, d, g, j H&E staining; b, e, h, k) immunohistochemical staining for N-terminal androgen-receptor full-length (AR-FL) and (c, f, i, l) immunohistochemical staining for AR-V7 in two representative tissue samples. The first and second rows are AR-V7-positive from consecutive tissue sections, and the third and fourth rows are AR-V7-negative. Original magnification: × 100 (a, b, c, g, h, i) and × 400 (d, e, f, j, k, l)

Back to article page